2025 |
Mckesson Corporation
|
Independent Director |
- |
- |
2024 |
Mckesson Corporation
|
Independent Director |
- |
- |
2024 |
Syros Pharmaceuticals Inc.
|
Independent Director |
- |
- |
2024 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
- |
- |
2023 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
459.9 K |
-0.5 % |
2023 |
Syros Pharmaceuticals Inc.
|
Independent Director |
79.1 K |
-56.4 % |
2022 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
462.2 K |
1.1 % |
2022 |
Syros Pharmaceuticals Inc.
|
Independent Director |
181.3 K |
28.4 % |
2021 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
457.1 K |
8.1 % |
2021 |
Syros Pharmaceuticals Inc.
|
Director |
141.2 K |
- |
2020 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
423.1 K |
7.4 % |
2019 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
393.9 K |
-25.2 % |
2018 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
526.7 K |
-35.7 % |
2017 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
819.6 K |
- |
2016 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
- |
- |